Differential Prognostic Value of Vascular Invasion in Resected Lung Adenocarcinomas According to Epidermal Growth Factor Receptor Mutational Status

It is unclear whether all patients with stage IB to IIIA epidermal growth factor receptor (EGFR)-mutant adenocarcinoma should receive adjuvant osimertinib. We investigated the prognostic value of vascular invasion for risk stratification according to EGFR mutational status. This retrospective study...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical lung cancer 2023-11, Vol.24 (7), p.e291-e299.e1
Hauptverfasser:	Lee, Kyung Hee, Chung, Jin-Haeng, Cho, Sukki, Lee, Jong-Seok, Kim, Hyungjin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma of lung Adjuvant chemotherapy Epidermal growth factor receptor mutation Prognosis Survival analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!